TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8576484

Group type: EXPERIMENTAL
Intervention: MR images (T1WFS and fast STIR)
Number of subjects: 39

Group type: COMPARATOR
Intervention: CT images
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: T1WFS and fast STIR images
Number of subjects: 39
Study: 1789393

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 6752250

Group type: EXPERIMENTAL
Intervention: Psychotherapy (weekly 30-50 minutes sessions of interpersonal psychotherapy)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (random assignment to either alprazolam, imipramine, or pill-placebo for six weeks)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Community publicity regarding psychotherapy treatment program
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inappropriate referrals for diagnostic reasons
Number of subjects: 18
Study: 29723080

Group type: EXPERIMENTAL
Intervention: Basic Body Awareness Therapy (BBAT)
Number of subjects: 41
Study: 28027282

Group type: EXPERIMENTAL
Intervention: Rifampin pretreatment (20 mg/kg) with ceftriaxone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ceftriaxone alone
Number of subjects: 40
Study: 26215900

Group type: EXPERIMENTAL
Intervention: Real-SNAG
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham-SNAG
Number of subjects: 32
Study: 23965805

Group type: COMPARATOR
Intervention: Rivaroxaban
Number of subjects: 0
Study: 20418510

Group type: EXPERIMENTAL
Intervention: Eltrombopag 100 mg once daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Eltrombopag 150 mg once daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Eltrombopag 200 mg once daily
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Eltrombopag (all doses)
Number of subjects: 33
Study: 19717248

Group type: EXPERIMENTAL
Intervention: Naltrexone (n=51)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (n=49)
Number of subjects: 100
Study: 17244834

Group type: EXPERIMENTAL
Intervention: Intervention group with contextualized intervention strategy (reinforced counseling, improved communication, decentralization of treatment, choice of DOT supporter, reinforcement of supervision activities)
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Control group with usual TB control program procedures
Number of subjects: 1522

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1522

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1522
Study: 15717874

Group type: EXPERIMENTAL
Intervention: BIAsp70
Number of subjects: 22

Group type: COMPARATOR
Intervention: BIAsp30
Number of subjects: 22
Study: 11838624

Group type: EXPERIMENTAL
Intervention: Amisulpride (50 mg/day)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Paroxetine (20 mg/day)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/day)
Number of subjects: 76
Study: 10530410

Group type: EXPERIMENTAL
Intervention: Large hospitals
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Intermediate hospitals
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Small hospitals
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Patients aged up to 70 years
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Patients older than 70 years
Number of subjects: 432
Study: 7722161

Group type: EXPERIMENTAL
Intervention: Physician-targeted educational program on inhaled therapy (45 minutes, one-on-two teaching sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 2031818

Group type: EXPERIMENTAL
Intervention: Inspired fractional oxygen concentration (FIO2) of 0.5
Number of subjects: 63

Group type: COMPARATOR
Intervention: Inspired fractional oxygen concentration (FIO2) of 0.33
Number of subjects: 63
Study: 7181048

Group type: EXPERIMENTAL
Intervention: Preseasonal hyposensitization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subsequent perennial treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal IgE response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: One year after the end of hyposensitization
Number of subjects: 0
Study: 31035775

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40
Study: 30380145

Group type: EXPERIMENTAL
Intervention: Laparoscopic spleen-preserving splenic hilar lymphadenectomy (LSPL)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Open spleen-preserving splenic hilar lymphadenectomy (OSPL)
Number of subjects: 222
Study: 26530478

Group type: EXPERIMENTAL
Intervention: Insorb absorbable staples
Number of subjects: 60

Group type: COMPARATOR
Intervention: Absorbable monofilament sutures
Number of subjects: 60
Study: 25162603

Group type: EXPERIMENTAL
Intervention: DETERx 40-mg capsules intact
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Crushed DETERx (using the most effective method established in vitro)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Chewed DETERx
Number of subjects: 44

Group type: COMPARATOR
Intervention: Oxycodone solution
Number of subjects: 44
Study: 22330958

Group type: EXPERIMENTAL
Intervention: DTPw-HBV-IPV/Hib vaccine (full-dose, half-dose, one-third dose)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group (DTPw-HBV/Hib and IPV vaccines administered separately)
Number of subjects: 312
Study: 21092015

Group type: EXPERIMENTAL
Intervention: Nurse telephone follow-up service for 3 months, twice per week for the first month and weekly for the second and third months.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no telephone follow-up).
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Nurse telephone follow-up service.
Number of subjects: 61
Study: 17645249

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at Ganshu (BL 18), Shenshu (BL 23), Xinshu (BL 15), once daily.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoxetine hydrochloride, 20 mg, once daily (control group).
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Acupuncture and Control).
Number of subjects: 60
Study: 17532693

Group type: EXPERIMENTAL
Intervention: CO2-releasing suppository
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 11695209

Group type: EXPERIMENTAL
Intervention: Colgate Total Plus Whitening Toothpaste
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Crest Multi‐Care Advanced Cleaning Toothpaste
Number of subjects: 100

Group type: COMPARATOR
Intervention: Colgate Winterfresh Gel
Number of subjects: 100
Study: 9615508

Group type: EXPERIMENTAL
Intervention: Nurses' self-descriptions and perceptions of their role in BCPT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nurses' perceptions of the role of women in BCPT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ethical and social issues raised by the inquiry
Number of subjects: 50
Study: 7643191

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate mouthwash
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 2.5 percent Lidocaine ointment
Number of subjects: 3

Group type: COMPARATOR
Intervention: Conventional eugenol‐impregnated iodoform gauze
Number of subjects: 3
Study: 2696231

Group type: EXPERIMENTAL
Intervention: Cefazolin (4 X 0.5 g intravenously)
Number of subjects: 883

Group type: COMPARATOR
Intervention: Ceftriaxone (2 g intravenously)
Number of subjects: 883
Study: 791478

Group type: EXPERIMENTAL
Intervention: DTIC (2 mg/kg/day X 10 iv)
Number of subjects: 50

Group type: COMPARATOR
Intervention: BCNU (150 mg/m2 iv) plus vincristine (2 mg/m2 iv on Day 1 only)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Secondary therapy after failure to respond to primary therapy
Number of subjects: 50
Study: 31909679

Group type: EXPERIMENTAL
Intervention: 6% citric acid (CA) + 1% sodium hypochlorite (NaOCl)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10% ethylenediaminetetraacetic acid (EDTA) + 1% sodium hypochlorite (NaOCl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% sodium hypochlorite (NaOCl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.9% physiological saline (PS)
Number of subjects: 0
Study: 29353709

Group type: EXPERIMENTAL
Intervention: Telenursing services (N=48) - weekly contact via telephone to motivate self-monitoring and healthy lifestyle.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard diabetes advice and care in the clinic (N=46).
Number of subjects: 94
Study: 27299859

Group type: EXPERIMENTAL
Intervention: COPERS intervention (cognitive behavioural approaches, delivered over three alternate days with a follow-up session at 2 weeks)
Number of subjects: 703

Group type: EXPERIMENTAL
Intervention: COPERS intervention
Number of subjects: 703

Group type: COMPARATOR
Intervention: Usual care and relaxation CD (control)
Number of subjects: 703
Study: 24472799

Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation using the Symplicity system
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Redo procedure for renal sympathetic denervation
Number of subjects: 93
Study: 22465608

Group type: EXPERIMENTAL
Intervention: Rotational angiography
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional coronary angiography
Number of subjects: 104
Study: 19890370

Group type: EXPERIMENTAL
Intervention: Amlodipine/benazepril (5/20 or 10/40 mg daily)
Number of subjects: 259

Group type: COMPARATOR
Intervention: Amlodipine (5 or 10 mg daily)
Number of subjects: 259
Study: 18332158

Group type: EXPERIMENTAL
Intervention: Nurse depression intervention (n = 164)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Usual primary care (n = 165)
Number of subjects: 329
Study: 15776333

Group type: EXPERIMENTAL
Intervention: Immediate pre-exercise, orally ingested sodium load (164 mEq Na+) (IPOSL), equivalent to 10 ml per kilogram of body weight.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo beverage (Pl), hypotonic (94 mOsm . kg (‐1)), no-sodium, equivalent to 10 ml . kg (‐1) body weight.
Number of subjects: 14
Study: 12589990

Group type: EXPERIMENTAL
Intervention: Post-course training
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Retention group (10+/−3 months after course)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Pre-course group
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Post-course group
Number of subjects: 165
Study: 10333375

Group type: EXPERIMENTAL
Intervention: Radiosurgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of surgery and radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 0
Study: 8738619

Group type: EXPERIMENTAL
Intervention: Cernilton
Number of subjects: 89

Group type: COMPARATOR
Intervention: Tadenan (Control)
Number of subjects: 89
Study: 2016227

Group type: EXPERIMENTAL
Intervention: High dose methylphenidate (0.8 mg/kg)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Low dose methylphenidate (0.4 mg/kg)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Behavioral parent training plus child self-control instruction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 6218649

Group type: EXPERIMENTAL
Intervention: Ipratropin followed by fenoterol or vice versa
Number of subjects: 22
Study: 31570565

Group type: EXPERIMENTAL
Intervention: Energetic self-management program (4-month group intervention)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study: 29412045

Group type: EXPERIMENTAL
Intervention: Oral contraceptive use for more than 1 year
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Oral contraceptive use
Number of subjects: 999
Study: 26945575

Group type: EXPERIMENTAL
Intervention: Flaminal®
Number of subjects: 90

Group type: COMPARATOR
Intervention: Flamazine®
Number of subjects: 90
Study: 24841099

Group type: EXPERIMENTAL
Intervention: Information confirming preferences
Number of subjects: 0

Group type: COMPARATOR
Intervention: Information disconfirming preferences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceived information quality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive feedback for confirming preferences
Number of subjects: 0
Study: 23204156

Group type: EXPERIMENTAL
Intervention: Walnut-enriched meat (WM)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional meat (CM)
Number of subjects: 22
Study: 20954968

Group type: EXPERIMENTAL
Intervention: rMenB+OMV
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: rMenB
Number of subjects: 147

Group type: COMPARATOR
Intervention: Single dose at 12 months
Number of subjects: 147
Study: 18408362

Group type: EXPERIMENTAL
Intervention: Deferasirox (5-30 mg/kg/day)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Deferoxamine (20-50 mg/kg, 5 days per week)
Number of subjects: 195
Study: 16029006

Group type: EXPERIMENTAL
Intervention: High vegetable and fruit diet (12.1 servings per day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Low vegetable and fruit diet (3.6 servings per day)
Number of subjects: 64
Study: 12414883

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10856311

Group type: EXPERIMENTAL
Intervention: Oxygen given before ascent
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oxygen given after ascent
Number of subjects: 18

Group type: COMPARATOR
Intervention: Air given before ascent
Number of subjects: 18

Group type: COMPARATOR
Intervention: Air given after ascent
Number of subjects: 18
Study: 9346222

Group type: EXPERIMENTAL
Intervention: Carboplatin/paclitaxel
Number of subjects: 518

Group type: COMPARATOR
Intervention: Cisplatin/paclitaxel
Number of subjects: 518
Study: 8251273

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine with clonidine 120 micrograms
Number of subjects: 42

Group type: COMPARATOR
Intervention: 0.125% bupivacaine
Number of subjects: 42
Study: 3739819

Group type: EXPERIMENTAL
Intervention: Behavior monitoring treatment
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (no behavior monitoring)
Number of subjects: 173
Study: 30486717

Group type: EXPERIMENTAL
Intervention: Aggressive fantasy condition
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 113
Study: 31332099

Group type: EXPERIMENTAL
Intervention: Weekly regimen (paclitaxel 90 mg/m2 on days 1, 8, and 15 with carboplatin AUC 6 on day 1 of every 4 weeks)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Biweekly regimen (paclitaxel 135 mg/m2 with carboplatin AUC 3 on days 1 and 15 of every 4 weeks)
Number of subjects: 140
Study: 29634142

Group type: EXPERIMENTAL
Intervention: Monotherapy with alpha-blockers
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of 5-alpha reductase inhibitors and alpha-blockers
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination drug Duodart
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 28797281

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied to the affected leg for 45 minutes daily, 5 days a week for 3 weeks at a frequency of 10 Hz and pulse width of 200 μs.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo stimulation (SHAM) delivered with the same modalities as TENS but with voltage falling to zero after 10 seconds.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TENS intervention.
Number of subjects: 100
Study: 26261157

Group type: EXPERIMENTAL
Intervention: Prior PPM
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: New PPM
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: LBBB/no PPM
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Prior PPM, New PPM, LBBB/no PPM
Number of subjects: 2531
Study: 23835365

Group type: EXPERIMENTAL
Intervention: Polaprezinc (PLZ) 150 mg/d (116 mg CAR and 34 mg zinc)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: L-carnosine (CAR) 116 mg/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 42
Study: 21502883

Group type: COMPARATOR
Intervention: CT (circuit training)
Number of subjects: 38

Group type: COMPARATOR
Intervention: CT + MI (circuit training + motivational interviewing)
Number of subjects: 38
Study: 18199798

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1435

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1435
Study: 17023720

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (250 mg vitamin C, 100 IU vitamin E, 37.5 mg selenium)
Number of subjects: 3411

Group type: EXPERIMENTAL
Intervention: Garlic supplementation (200 mg aged garlic extract and 1 mg steam-distilled garlic oil, twice daily)
Number of subjects: 3411

Group type: EXPERIMENTAL
Intervention: Short-term amoxicillin (1 g) and omeprazole (20 mg) treatment
Number of subjects: 3411
Study: 12710322

Group type: EXPERIMENTAL
Intervention: DER + 5 J
Number of subjects: 96

Group type: COMPARATOR
Intervention: DER + 10 J
Number of subjects: 96
Study: 10745279

Group type: EXPERIMENTAL
Intervention: Yoghurt fermented with one strain of Enterococcus faecium and two strains of Streptococcus thermophilus (CAUSIDO(R) culture), GAIO(R) (G)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Yoghurt fermented with two strains of Streptococcus thermophilus and two strains of Lactobacillus acidophilus (StLa)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo pills (PP)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Yoghurt fermented with two strains of Streptococcus thermophilus and one strain of Lactobacillus rhamnosus (StLr)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Placebo yoghurt fermented with delta‐acid‐lactone (PY)
Number of subjects: 70
Study: 8734726

Group type: EXPERIMENTAL
Intervention: Hotz's plate
Number of subjects: 20

Group type: COMPARATOR
Intervention: No Hotz's plate
Number of subjects: 20
Study: 1531820

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 31711737

Group type: EXPERIMENTAL
Intervention: Moderate hypofractionation for prostate cancer radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Seven or less fractions
Number of subjects: 0
Study: 30854452

Group type: EXPERIMENTAL
Intervention: Stage (univariate predictor)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: MTV plus penumbra texture feature (added to stage)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Multivariate model (including stage and MTV plus penumbra texture feature)
Number of subjects: 291
Study: 28353040

Group type: EXPERIMENTAL
Intervention: 5% phenylbutyrate mouthwash
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26551263

Group type: EXPERIMENTAL
Intervention: 25 mg of velpatasvir once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25 mg of velpatasvir plus ribavirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg of velpatasvir once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg of velpatasvir plus ribavirin
Number of subjects: 0
Study: 23648576

Group type: EXPERIMENTAL
Intervention: Epinephrine-soaked cottonoid
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline-soaked cottonoid
Number of subjects: 43
Study: 21134456

Group type: EXPERIMENTAL
Intervention: Hexavalent vaccine formulations (PRP-T, 12μg; PRP-OMPC, 3μg or 6μg)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Hexavalent vaccine formulations (PRP-OMPC, 3μg or 6μg)
Number of subjects: 756

Group type: COMPARATOR
Intervention: Control group (0.5mL intramuscular dose of diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b+hepatitis B vaccine)
Number of subjects: 756
Study: 20407301

Group type: EXPERIMENTAL
Intervention: High-frequency (10 Hz) stimulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Low-frequency (1 Hz) stimulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All groups (including low-frequency and sham)
Number of subjects: 18
Study: 17174559

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) infusion at a dose of 0.1mg/kg/h during rewarming period of CPB
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no SNP infusion)
Number of subjects: 240
Study: 16686066

Group type: EXPERIMENTAL
Intervention: CEUS Group (81 patients undergoing CEUS before RFA)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control Group (83 patients not undergoing CEUS before RFA)
Number of subjects: 164
Study: 12483170

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (0.5 microg/kg/min for 20 min after aortic crossclamp release)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no sodium nitroprusside)
Number of subjects: 20
Study: 9665357

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 10
Study: 7647542

Group type: EXPERIMENTAL
Intervention: Buyang Huanwu Decoction (BYHWD)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 2620311

Group type: EXPERIMENTAL
Intervention: Step exercise test in hypoxia
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ramp exercise test in hypoxia
Number of subjects: 8
Study: 8413

Group type: EXPERIMENTAL
Intervention: Health assistant guided by the protocol and supported by an available physician
Number of subjects: 567

Group type: COMPARATOR
Intervention: Physician only
Number of subjects: 567
Study: 30892797

Group type: EXPERIMENTAL
Intervention: Sonic toothbrush + 0.12% chlorhexidine (CHX) rinsing
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.12% chlorhexidine (CHX) rinsing + manual toothbrush on day 14
Number of subjects: 30
Study: 27646937

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.1 μg/kg/min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.2 μg/kg/min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.3 μg/kg/min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups (including all doses of remifentanil)
Number of subjects: 90
Study: 27941730

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day) for 12 weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day) for 12 weeks in participants with higher baseline serum uric acid levels
Number of subjects: 98